Genetic Signatures Share Price and Company Fundamentals



Price
$1.505
Change
-0.015 (-0.987%)
52 week
1.04 - 2.13

Last traded: Last Friday at 5:26 AM

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, North America, Europe, the Middle East, and Africa. The company designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under EasyScreen brand name. It also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. The company was incorporated in 2001 and is based in Newtown, Australia.

Key Metrics

PE ratio

125.42

PB ratio

4.36

Dividend yield

Beta

-0.44

Market cap

$215.27M

Enterprise value

$185.35M

Company profile

Primary activitiesMolecular Diagnostics.
Industry / SectorDiagnostics & Research / Healthcare
Websitehttp://www.geneticsignatures.com
Mailing address7 Eliza Street Newtown NSW 2042 Australia
Phone / Fax61 2 9870 7580 /
Share registryBOARDROOM PTY LIMITED

Dividends

Genetic Signatures does not pay dividends.

Company Executives

As of Sep 2021, following are the company executives and directors listed on Genetic Signatures.

NameTitleAgeTotal Pay
Dr. John R. MelkiMD, CEO & Exec. Director483.01k
Mr. Peter L. Manley CPACFO & Company Sec.285.37k
Mr. Michael Anton Aicher M.B.A., BSc, MBAExec. Director of US Operations & Exec. Director60161.55k
Mr. Christopher M. AbbottFounder & Chairman Emeritus
Dr. Douglas S. Millar BSc, Ph.D.Chief Scientific Officer
Mr. Jackson Jones B.Sc.Director of Global Sales & Marketing

Profitability and management effectiveness

Profit margin

6.19%

Operating margin

5.38%

Return on assets

1.84%

Return on equity

3.69%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Genetic Signatures is 215.27M and its enterprise value is 185.35M. The enterprise value to revenue ratio of GSS is 6.53.

Companies similar to Genetic Signatures (GSS)

Genetic Signatures (ASX:GSS) Frequently Asked Questions

1. What is Genetic Signatures's Stock Symbol?

Genetic Signatures trades on ASX under the ticker symbol "GSS".

2. What is Genetic Signatures's stock price today?

One share of GSS stock can currently be purchased for approximately $1.505.

3. How can I contact Genetic Signatures?

Genetic Signatures's mailing address is 7 Eliza Street Newtown NSW 2042 Australia. The company can be reached via phone at 61 2 9870 7580.

4. What is Genetic Signatures's official website?

The official website of Genetic Signatures is http://www.geneticsignatures.com.

5. Which share registry manages Genetic Signatures's stock?

Genetic Signatures's stock is managed by BOARDROOM PTY LIMITED.